Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes
Crossref DOI link: https://doi.org/10.1007/s13346-017-0368-5
Published Online: 2017-03-17
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gu, Jijin
Al-Bayati, Karam
Ho, Emmanuel A.
Funding for this research was provided by:
Manitoba Health Research Council
License valid from 2017-03-17